Various animal models of MASLD showed downregulation in relative CAT mRNA expression in the liver (Nayan et al. 2021; Park et al. 2016; Pereira et al. 2017; Santos-López et al. 2016; Xia et al. 2016, 2018). Here, CAT is linked to metabolic dysfunction-associated steatotic liver disease.